Helios Kliniken Emil-von-Behring

Berlin 14165

0 studies enrolling now · 1 studies all time

What they study most

Small Cell Lung Cancer (SCLC)

Studies at this site

• A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC — Running, not enrolling